Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

• Published in: Journal of the American College of Cardiology Vol. 75; no. 17; pp. 2122 - 2135
• Main Authors: Duran, Edward K., Aday, Aaron W., Cook, Nancy R., Buring, Julie E., Ridker, Paul M, Pradhan, Aruna D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 05.05.2020
• Subjects: atherogenesis; biomarkers; Cardiovascular; Cardiovascular Diseases - blood; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - epidemiology; Cholesterol - blood; Cholesterol, LDL - blood; Cohort Studies; dyslipidemia; epidemiology; Female; Follow-Up Studies; Humans; Incidence; Lipoproteins - blood; Male; Middle Aged; primary prevention; Prospective Studies; Triglycerides - blood; vascular disease; atherogenesis; TRL-C; WHS; biomarkers; HR; IS; CVD; epidemiology; CCVD; PAD; vascular disease; primary prevention; hsCRP; sdLDL-C; dyslipidemia; MI; triglyceride-rich lipoprotein cholesterol; myocardial infarction; high-sensitivity C-reactive protein; ischemic stroke; cardiovascular disease; peripheral artery disease; small-dense low-density lipoprotein cholesterol; coronary and cerebrovascular disease; Women’s Health Study; hazard ratio
• ISSN: 0735-1097; 1558-3597; 1558-3597
• DOI: 10.1016/j.jacc.2020.02.059

Elevated triglyceride-rich lipoprotein (TRL) and small-dense low-density lipoprotein (sdLDL) particles are hallmarks of atherogenic dyslipidemia, and their cholesterol content is hypothesized to drive atherosclerotic risk. Prospective epidemiological data pertaining to cholesterol content of TRLs and sdLDL in primary prevention populations are mostly limited to coronary heart disease. The purpose of this study was to prospectively evaluate whether triglyceride-rich lipoprotein cholesterol (TRL-C) and small-dense low-density lipoprotein cholesterol (sdLDL-C) concentrations associate with composite and individual incident cardiovascular disease (CVD) outcomes including myocardial infarction (MI), ischemic stroke (IS), and peripheral artery disease (PAD). In a prospective case-cohort study within the Women’s Health Study, TRL-C and sdLDL-C (mg/dl) were directly measured in baseline blood specimens of case subjects (n = 480) and the reference subcohort (n = 496). Risk associations were evaluated for total CVD (MI, IS, PAD, and CVD death), coronary and cerebrovascular disease (MI, IS, CVD death), and individual outcomes (MI, IS, and PAD). Models were adjusted for traditional risk factors, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein. The risk of both composite outcomes significantly increased across quartiles of TRL-C and sdLDL-C. TRL-C was significantly associated with MI and PAD (MI hazard ratio [HR]Q4: 3.05 [95% confidence interval (CI): 1.46 to 6.39]; ptrend = 0.002; PAD HRQ4: 2.58 [95% CI: 1.18 to 5.63]; ptrend = 0.019), whereas sdLDL-C was significantly associated with MI alone (HRQ4: 3.71 [95% CI: 1.59 to 8.63]; ptrend < 0.001). Both markers weakly associated with IS. Association patterns were similar for continuous exposures and, for TRL-C, among subjects with low atherogenic particle concentrations (apolipoprotein B <100 mg/dl). TRL-C strongly associates with future MI and PAD events, whereas sdLDL-C strongly associates with MI alone. These findings signal that the cholesterol content of TRLs and sdLDL influence atherogenesis independently of low-density lipoprotein cholesterol, and high sensitivity C-reactive protein, with potentially different potency across vascular beds. (Women’s Health Study; NCT00000479) [Display omitted]